Therapeutic Research Protocol Dose: 1.2 2.4 mg (= 4896 clicks) Duration: 12 20 weeks Frequency: Once weekly Cycle Interval: 4 6 weeks off before repeating Goal / Description: Higher-dose protocol used in obesity research to evaluate sustained satiety and adiposity reduction
During your consultation, the physician will cover all the details youll need to know to ensure your treatment is easy, quick, and produces wonderful results
Neuroprotection: BPC-157 has demonstrated neuroprotective capabilities in preclinical studies
In April 2026 the FDA removed BPC-157 along with a number of other peptides, TB-500 among them from the Section 503A Category 2 list that had restricted compounding, and a Pharmacy Compounding Advisory Committee meeting on 2324 July 2026 is due to consider them further
Here at Real Peptides, our team has spent years not just synthesizing high-purity peptides, but also consulting with researchers on the protocols that ensure those peptides yield clean, repeatable data
